Liberator Medical Holdings reports record net revenues for fiscal year 2009

NewsGuard 100/100 Score

Liberator Medical Holdings, Inc. (OTCBB: LBMH) announced net revenues for fiscal year 2009 of $25,818,000, representing an increase of $16,268,000, or 170.3%, compared with fiscal year 2008. The increase in sales occurred in the mail order segment of its business. The increase was due to a substantial direct-response advertising campaign to obtain new mail order customers.

The Company reported gross profit for fiscal year 2009 of $16,768,000, representing an increase of $10,657,000, or 174.4%, compared with fiscal year 2008. As a percentage of sales, gross profit improved by 0.9% to 64.9% of sales for fiscal year 2009 compared to 64.0% of sales for fiscal year 2008. The increase in profit margins is primarily the result of vendor price reductions and/or discounts due to increased sales volumes.

The Company reported net income of $2,222,000 ($0.07 per share) for the fiscal year ended September 30, 2009, an increase of $3,531,000 compared to a net loss of $1,309,000 for the fiscal year ended September 30, 2008. During fiscal year 2009, cash provided by operating activities was $1,712,000.

For the fourth fiscal quarter 2009, the Company reported net revenues of $7,698,511, representing an increase of $3,447,670, or 81%, over fourth fiscal quarter 2008 net revenues of $4,250,841. During the fiscal fourth quarter, the Company reported net income of $1.087 million ($0.03 per share), compared to net income of $133,000 ($0.01 per share) for the fiscal fourth quarter 2008, an increase of $954,000, or 717%.

The Company invested $4,191,000 in direct-response advertising during fiscal year 2009, representing an increase of $2,624,000, or 167.5%, compared with fiscal year 2008. The Company believes that this investment in advertising was the driving force that helped catapult its year-over-year net revenue growth.

As of September 30, 2009, the Company had cash of $3,798,000, an increase of $2,625,000 compared to cash of $1,173,000 at September 30, 2008. This increase in cash in 2009 is primarily due to net proceeds of $2,177,000 from a long-term convertible debt offering in October 2008 and $1,712,000 generated from operating activities during fiscal year 2009, partially offset by cash used to purchase a $500,000 certificate of deposit as security for a new credit line, $441,000 for purchases of property and equipment, and payments of $316,000 on debt and capital lease obligations.

Mr. Libratore, CEO, stated: "The Company has experienced tremendous growth over the past two years and, as a result, five consecutive profitable quarters while generating positive operating cash flows during fiscal year 2009. We believe we have built an infrastructure and business model that it is capable of generating a substantially higher sales volume at reduced levels of incremental cost. In an effort to continue our growth, we plan on accelerating our advertising efforts over the next twelve months to attract new customers and expand our operations to service our new and existing customers. The outlook for demand for our products and services is favorable, as there should be an increase in newly-diagnosed patients requiring the medical supplies that we provide. We expect our revenues to increase significantly over the next twelve months due to our advertising and marketing programs."

SOURCE: Liberator Medical Holdings, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.